BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11216553)

  • 21. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
    Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
    Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal transport after long-term exposure to Icodextrin in rats.
    Frajewicki V; Kushnir D; Wajsbrot V; Kohan R; Shostak A; Gotloib L
    Nephron; 2002 Sep; 92(1):174-82. PubMed ID: 12187100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
    Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal accumulation of AGE and peritoneal membrane permeability.
    Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
    Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily exposure to dialysis fluid results in changes in peritoneal transport.
    Wang T; Qureshi AR; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Perit Dial Int; 1997; 17(4):379-86. PubMed ID: 9284466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions.
    Ahmad M; Shah H; Pliakogiannis T; Oreopoulos DG
    Int Urol Nephrol; 2007; 39(1):299-312. PubMed ID: 17004033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
    Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
    Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
    Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
    Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children.
    Rusthoven E; Krediet RT; Willems HL; Monnens LA; Schröder CH
    J Am Soc Nephrol; 2004 Nov; 15(11):2940-7. PubMed ID: 15504948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.